Abstract
In-depth multiomics phenotyping can provide a molecular understanding of complex physiological processes and their pathologies. Here, we report on the application of 18 diverse deep molecular phenotyping (omics-) technologies to urine, blood, and saliva samples from 391 participants of the multiethnic diabetes study QMDiab. We integrated quantitative readouts of 6,304 molecular traits with 1,221,345 genetic variants, methylation at 470,837 DNA CpG sites, and gene expression of 57,000 transcripts using between-platform mutual best correlations, within-platform partial correlations, and genome-, epigenome-, transcriptome-, and phenome-wide associations. The achieved molecular network covers over 34,000 statistically significant trait-trait links and illustrates “The Molecular Human”. We describe the variances explained by each omics layer in the phenotypes age, sex, BMI, and diabetes state, platform complementarity, and the inherent correlation structures of multiomics. Finally, we discuss biological aspects of the networks relevant to the molecular basis of complex disorders. We developed a web-based interface to “The Molecular Human”, which is freely accessible at http://comics.metabolomix.com and allows dynamic interaction with the data.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by Biomedical Research Program funds at Weill Cornell Medicine in Qatar, a program funded by the Qatar Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Institutional Review Boards of HMC and Weill Cornell Medicine, Qatar (WCM-Q) (research protocol #11131/11). Written informed consent was obtained from all participants.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
